ZD6474

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

ZD6474 to Treat Advanced Brain Cancer in Patients

Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors

Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer

Phase II Study of ZD6474 in Advanced NSCLC

Malignant Pleural Effusion With ZD6474

BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck

ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer

ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma